Worked demonstration
Payer Risk & Value
Open the worked demonstration for this journey. Every screen is labelled synthetic and nonclinical.
Solutions
Three domain journeys, one governed substrate
The same evidence layer serves three audiences. What differs is the question, the permitted use of the output, and the conditions under which the platform declines to answer.
Health plans, employers and their analytic teams
Payer Risk & Value
Decide where intervention value is concentrated and what evidence supports it, without merging incompatible bases.
Journey definition
| Dimension | Definition |
|---|---|
| Audience | Plan analysts, medical policy, pharmacy, HEOR |
| Question answered | Where is value concentrated across a population, and how confident can we be? |
| Workflow | Portfolio → intervention library → question builder → population → effectiveness → HEOR → UM/PA → monitoring |
| Controlled output | Population-level synthetic findings with evidence completeness and governance status; never an individual risk claim |
| Refusal conditions | Missing connectors, absent outcome return, unvalidated artifacts |
Clinicians and clinical review teams
Clinical Pathways
Bring pathway context, evidence and policy to a synthetic case without automating the decision.
Journey definition
| Dimension | Definition |
|---|---|
| Audience | Treating clinicians, clinical reviewers, care management |
| Question answered | What does the pathway and the governed record support for this case? |
| Workflow | Work queue → case summary → pathway explorer → treatment selection → UM navigator → member impact → follow-up |
| Controlled output | Synthetic case context with evidence and policy shown separately, plus access and burden implications |
| Refusal conditions | Unknown or contradicted facts, missing indication protocol, experimental artifact |
Worked demonstration
Clinical Pathways
Open the worked demonstration for this journey. Every screen is labelled synthetic and nonclinical.
Life sciences and research organisations
Life Sciences & RWE
Specify a target trial, test whether a comparator is fit for purpose, and release an estimate only after the validity gates pass.
Journey definition
| Dimension | Definition |
|---|---|
| Audience | Epidemiologists, biostatisticians, RWE and regulatory scientists |
| Question answered | Compared with a fit-for-purpose external comparator, what would outcomes have been under the alternative strategy? |
| Workflow | Research portfolio → feasibility → protocol builder → ECA workbench → RWE methods → results → replay |
| Controlled output | A gated estimate with a replay manifest, or a refusal carrying an explicit code |
| Refusal conditions | Inadequate overlap, positivity not established, comparator not fit for purpose, no canonical run output |
Worked demonstration
Life Sciences & RWE
Open the worked demonstration for this journey. Every screen is labelled synthetic and nonclinical.